Transplantation of islets using microencapsulation: Studies in diabetic rodents and dogs

Journal of Molecular Medicine

Volumn 77, Issue 1, 1999, Pages 206-210

  Lanza, Robert P ^a   Ecker, Dawn M ^a   Kühtreiber, Willem M ^a   Marsh, Joanne P ^a   Ringeling, John ^a   Chick, William L ^a  

^a BioHybrid Technologies Inc   (United States)

Author keywords

Diabetes; Encapsulation; Immunoisolation; Islets of Langerhans; Xenotransplantation

Indexed keywords

CYCLOSPORIN A; GLUCOSE; INSULIN;

ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; DOG; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; INSULIN TREATMENT; MALE; MICROENCAPSULATION; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET TRANSPLANTATION; XENOTRANSPLANTATION;

EID: 0033011250     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050337     Document Type: Conference Paper

References (15)

1. 1. Colton CK (1994) Implantable biohybrid artificial organs. Cell Transplant 4:415-436
2. 2. Lanza RP, Hayes JL, Chick WL (1996) Encapsulated cell technology: moving to the marketplace. Nature Biotechnology 14: 1107-1111
3. 3. Zielinski BA, Goddard MB, Lysaght MJ (1997) Immunoisolation. In: Lanza RP, Langer R, Chick WL (eds) Principles of Tissue Engineering. Academic Press, San Diego, pp 321-326
4. 4. Wang T, Lacík I, Brissová M et al (1997) An encapsulation system for the immunoisolation of pancreatic islets. Nature Biotechnology 15:358-362
5. 5. Avgoustiniatos ES, Colton CK (1997) Design considerations in immunoisolation. In: Lanza RP, Langer R, Chick WL (eds) Principles of Tissue Engineering. Academic Press, San Diego, pp 333-346
6. 6. Lanza RP, Chick WL (1997) Immnoisolation: at a turning point. Immunology Today 18:135-139
7. 7. Anderson A (1979) Survival of pancreatic islet allografts. Lancet 2:585
8. 8. Theodorou N, Howell S (1979) An assessment of diffusion chambers for use in pancreatic islet cell transplantation. Transplantation 27:350-352
9. 9. Warnock GL, Rajotte RV (1988) Critical mass of purified islets that induce normoglycemia after implantation into diabetic dogs. Diabetes 37:467-470
10. 10. Lanza RP, Butler DH, Borland KM et al (1991) Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci USA 88:11100-11104
11. 11. Lanza RP, Kühtreiber WM, Ecker D et al (1995) Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 59:1377-1384
12. 12. Lanza RP, Borland KM, Lodge P et al (1992) Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 41:886-889
13. 13. Moorhouse JA, Grahame GR, Rosen NJ (1964) Relationship between intravenous glucose tolerance and fasting blood glucose level in healthy and diabetic subjects. J Clin Endocrinol 24:145-159
14. 14. Lim F, Sun AM (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908-910
15. 15. Soon-Shiong P, Feldman E, Nelson R et al (1992) Successful reversal of spontaneously diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54:769-774